You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

940 Results
Statistical Reports
Jan 2018
Statistical Reports
Aug 2020
Statistical Reports
Nov 2022
Statistical Reports
Aug 2020
Statistical Reports
Apr 2023
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Sacituzumab Govitecan - Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer
New Drug Funding Program
    Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
sacituzumab govitecan
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Drug
Other Name(s): Trodelvy®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2025

Pages